AI assistant
Sending…
IDEXX LABORATORIES INC /DE — Director's Dealing 2018
Aug 9, 2018
30016_dirs_2018-08-09_d3c05854-48f7-4b75-af42-c4341cc69620.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2018-08-07
Reporting Person: SZOSTAK M ANNE (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-08-07 | Common Stock | G | 12000 | — | Disposed | 3416 | Indirect |
| 2018-08-07 | Common Stock | G | 12000 | — | Acquired | 12000 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 584 | Direct |
Footnotes
F1: These shares have been transferred from the M. Anne Szostak Trust (the 'Trust') to the 2018 Szostak IDEXX GRAT (the 'GRAT'). The reporting person is the settlor and trustee of the GRAT. The GRAT is irrevocable, and the reporting person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest in the GRAT.
More from IDEXX LABORATORIES INC /DE
Regulatory Filings
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Interim / Quarterly Report
2026
May 5
Earnings Release
2026
May 5
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Board/Management Information
2026
Mar 26